Dexamethasone/Piperacillin/Tazobactam

地塞米松/哌拉西林/他唑巴坦

Report date: 2023/08/22 17:10:42

Base Information

Drug NameDexamethasone/Piperacillin/Tazobactam

Drug Alias Namepiperacillin + tazobactam + dexamethasone他唑巴坦/地塞米松/哌拉西林哌拉西林钠/地塞米松/他唑巴坦钠Tazobactam/Piperacillin/DexamethasoneTazobactam/Dexamethasone/Piperacillin +[13]

ClassificationSmall molecules > Steroids

Mechanisms of ActionBeta Lactamase inhibitorsGlucocorticoid receptor agonists

TargetsBeta LactamaseGlucocorticoid receptor

Therapy Area/IndicationsOtitis MediaEar Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Dexamethasone Tazobactam Sodium Piperacillin Sodium

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesYuhan Corp

China Registration ClassN/A

Develop Information

Active CompaniesYuhan Corp

Inactive CompaniesN/A

Active IndicationsOtitis MediaEar Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A